Is thrombotic event a side effect of oral buprenorphine abuse? Two case reports. Issue 4 (3rd March 2019)

• Record Type: Journal Article
• Authors: Alirezaei, Toktam; Hajimoradi, Behzad
• Is Part Of: Clinical case reports. Volume 7:Issue 4(2019)
• Page Start: 740
• Page End: 743
• Publication Date: 2019-03-03
• Subjects: myocardial infarction -- oral buprenorphine -- pulmonary embolism -- thrombotic event; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.2086
• Languages: English
• ISSNs: 2050-0904

Abstract

Key Clinical Message: Buprenorphine is used to treat opioid addiction. The spectrum of complications of oral buprenorphine is not well known. We describe two cases and based on a hypothesis is proposed which suggests that the use of oral buprenorphine could be relevant to the increase of thrombotic risk. Abstract : Buprenorphine is used to treat opioid addiction. The spectrum of complications of oral buprenorphine is not well known. We describe two cases and based on a hypothesis is proposed which suggests that the use of oral buprenorphine could be relevant to the increase of thrombotic risk.